[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 2,159
Sort by:
Alzheimer's Disease - Pipeline Review, H2 2020 US$ 2,500.00

... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 1785 pages
Dyslipidemia - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Dyslipidemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 345 pages
Epilepsy - Pipeline Review, H2 2020 US$ 2,000.00

... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 662 pages
Atrial Fibrillation - Pipeline Review, H2 2020 US$ 2,000.00

... latest pipeline guide Atrial Fibrillation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Atrial Fibrillation (Cardiovascular) List of TablesNumber of Products under Development for Atrial Fibrillation, H2 2018 9Number of Products under Development ...

August 2020 134 pages
Duchenne Muscular Dystrophy - Pipeline Review, H2 2020 US$ 2,000.00

... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 413 pages
Genital Herpes - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 123 pages
Osteoarthritis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 384 pages
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020 US$ 2,000.00

... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

August 2020 184 pages
Liver Cirrhosis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Liver Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 158 pages
Osteosarcoma - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 868 pages
Anal Cancer - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 589 pages
Bronchopulmonary Dysplasia - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Bronchopulmonary Dysplasia (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchopulmonary Dysplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 81 pages
Restenosis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 39 pages
Pulmonary Embolism - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Pulmonary Embolism (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Embolism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 56 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020 US$ 2,000.00

... . The Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Muscular Atrophy (SMA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

August 2020 164 pages
Burns - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 111 pages
Pruritus - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 206 pages
Candidiasis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 225 pages
Cough - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 116 pages
Diabetic Nephropathy - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 269 pages
Ocular Hypertension - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 145 pages
Oral Mucositis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 66 pages
Polycythemia Vera - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Polycythemia Vera (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 132 pages
Blepharitis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 63 pages
Fabry Disease - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Fabry Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fabry Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 126 pages
Grass Pollen Allergy - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Grass Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 80 pages
Seborrhea - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Seborrhea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Seborrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 50 pages
Diabetic Gastroparesis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 68 pages
Myocardial Ischemia - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 90 pages
Nasopharyngeal Cancer - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 854 pages
Primary Immune Deficiency (PID) - Pipeline Review, H2 2020 US$ 2,000.00

... . The Primary Immune Deficiency (PID) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Primary Immune Deficiency (PID) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 134 pages
Rectal Cancer - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 245 pages
Cat Allergy - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Cat Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cat Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 31 pages
Dementia - Pipeline Review, H2 2020 US$ 2,000.00

... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 537 pages
Thalassemia - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 215 pages
Leiomyosarcoma - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 642 pages
Drug Addiction - Pipeline Review, H2 2020 US$ 2,000.00

... . The Drug Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Drug Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 216 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 211 pages
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 631 pages
Viral Conjunctivitis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 52 pages
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2020 US$ 2,000.00

... Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Juvenile Macular Degeneration (Stargardt Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 104 pages
Batten Disease - Pipeline Review, H2 2020 US$ 2,000.00

... . The Batten Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 93 pages
African Trypanosomiasis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The African Trypanosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for African Trypanosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 68 pages
Arrhythmias - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 86 pages
Encephalomyelitis - Pipeline Review, H2 2020 US$ 2,000.00

... . The Encephalomyelitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 62 pages
Periodontitis - Pipeline Review, H2 2020 US$ 2,000.00

... And Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Periodontitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 57 pages
Gonorrhea - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Gonorrhea (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Gonorrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 130 pages
Myocarditis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

August 2020 50 pages
Cryptococcosis - Pipeline Review, H2 2020 US$ 2,000.00

... releases. The Cryptococcosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptococcosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 59 pages
Becker Muscular Dystrophy - Pipeline Review, H2 2020 US$ 2,000.00

... . The Becker Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Becker Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 95 pages

Filters

Search

Categories

1,443
155
10
6
1
1
1
4
529
3
6

Publishers

2,159

Regions

2,159

Price

Date

Pages

Offers